| 引用本文: | 韩康鑫,孙卓森,翟丽,刘敏.基于PI3K/AKT通路研究川穹嗪衍生物对脑缺血再灌注损伤的保护作用及作用机制[J].中国现代应用药学,2026,43(19):33-46. |
| han kangxin,sun zhuosen,zhai li,liu min.HCTMPPK based on PI3K/Akt signaling pathway to alleviate cerebral ischemia-reperfusion injury of protection and mechanism research[J].Chin J Mod Appl Pharm(中国现代应用药学),2026,43(19):33-46. |
|
| |
|
|
| 本文已被:浏览 26次 下载 12次 |
 码上扫一扫! |
| 基于PI3K/AKT通路研究川穹嗪衍生物对脑缺血再灌注损伤的保护作用及作用机制 |
|
韩康鑫1, 孙卓森2, 翟丽2, 刘敏2
|
|
1.大连医科大学,青岛市市立医院;2.青岛市市立医院
|
|
| 摘要: |
| 目的? 探讨2-羟基-5-氯苯基-3-(3,5,6-三甲基吡嗪-2-基)-2-丙烯-1-酮(HCTMPPK)对脑缺血再灌注损伤(Cerebral ischemia-reperfusion injury,CIRI)的保护作用及机制。 方法? 建立大鼠肾上腺髓质嗜铬细胞瘤细胞(PC12)的氧-葡萄糖剥夺-复氧(Oxygen-glucose deprivation reperfusion,OGD/R)模型,应用CCK-8法检测细胞存活率,活性氧试剂盒检测活性氧(reactive oxygen species,ROS)的水平,丙二醛比色法(TBA法)检测丙二醛(malondialdehyde,MDA)的含量,流式细胞术检测细胞的凋亡率,免疫蛋白印迹法(Western blot)检测Bcl-2/Bax、Caspase-3/Cleaved Caspase-3、p-PI3K、PI3K、p-AKT和AKT的蛋白表达量,RT-qPCR检测PI3K和AKT的mRNA的表达水平。采用线栓法建立SD大鼠的大脑中动脉闭塞(middle cerebral artery occlusion,MACO)模型。采用mNSS法对大鼠进行神经功能评分,TTC染色法测定脑梗死体积,原位细胞凋亡TUNEL法检测细胞的凋亡率。 结果? 细胞实验结果表明,与模型组相比,HCTMPPK组的细胞存活率明显升高(P<0.05),ROS水平明显下降(P<0.05),MDA含量明显减少(P<0.05),细胞凋亡率明显降低(P<0.05)。Bax/Bcl-2和Cleaved Caspase-3/Caspase-3的蛋白比值明显降低(P<0.05),p-PI3K/PI3K和p-AKT/AKT的蛋白比值明显升高(P<0.05),PI3K和AKT的mRNA表达水平明显升高(P<0.05)。动物实验结果表明,HCTMPPK组大鼠神经学行为学评分明显降低(P<0.05),脑部梗死体积明显减小(P<0.05),细胞凋亡率明显降低(P<0.05)。 结论 HCTMPPK可能是通过减轻OGD/R后细胞的ROS水平和MDA含量,抑制缺氧缺糖后细胞的氧化应激反应,并可能通过下调Bax、Caspase-3和Cleaved Caspase-3蛋白的表达,上调Bcl-2、p-PI3K/PI3K和p-AKT/AKT蛋白的表达,减轻细胞凋亡、缩小I/R大鼠缺血组织的梗死面积,从而对卒中大鼠的脑组织起到保护作用。 |
| 关键词: 川芎嗪查尔酮类化合物 HCTMPPK 氧-糖剥夺 脑缺血再灌注 PI3K/Akt[1] |
| DOI: |
| 分类号:R284.1;R917.101?????? |
| 基金项目:中国青年创业就业基金会课题 |
|
| HCTMPPK based on PI3K/Akt signaling pathway to alleviate cerebral ischemia-reperfusion injury of protection and mechanism research |
|
han kangxin1, sun zhuosen, zhai li, liu min2
|
|
1.Dalian Medical University;2.Qingdao Municipal Hospital
|
| Abstract: |
| To investigate the protective effect and mechanism of 2-hydroxy-5-chlorophenyl-3-(3,5,6-trimethylpyrazin-2-yl)-2-propen-1-one (HCTMPPK) on cerebral ischemia-reperfusion injury (CIRI). METHODS The model of oxygen-glucose deprivation followed by reperfusion (OGD/R) was established using rat adrenal medullary pheochromocytoma cells (PC12). The CCK-8 method was employed to assess the survival rate of PC12 cells, the levels of reactive oxygen species (ROS) were measured using a ROS detection kit, while malondialdehyde (MDA) content was quantified via the thiobarbituric acid (TBA) method. Apoptosis rates in PC12 cells were evaluated through flow cytometry. Protein expression levels of Bcl-2, Bax, Caspase-3, Cleaved Caspase-3, p-PI3K, PI3K, p-AKT, and AKT in PC12 cells were analyzed by Western blotting. Additionally, mRNA expression levels of PI3K and AKT were determined using RT-qPCR. A middle cerebral artery occlusion (MCAO) model of SD rats was established by the suture method. The neurological function of rats was scored by mNSS method. Cerebral infarction volume was assessed through TTC staining techniques. Furthermore, cell apoptosis rates were detected using the TUNEL assay. RESULTS The results of the cell experiments indicated the cell survival rate in the HCTMPPK group was significantly increased (P<0.05), the ROS level was significantly decreased (P<0.05), the MDA content was significantly reduced (P<0.05), and the apoptosis rate was significantly decreased (P<0.05) when compared to the model group. The protein ratios of Bax/Bcl-2 and Cleaved Caspase-3/Caspase-3 markedly reduced (P<0.05), while the protein ratios of p-PI3K/PI3K and p-AKT/AKT were significantly increased (p<0.05), along with elevated mRNA expression levels of PI3K and AKT (p<0.05). In animal experiments, it was observed that after HCTMPPK treatment, there was a significant decrease in neurological scores in rats (P < 0.05), as well as a notable reduction in cerebral infarction volume (P<0.05), and a significant decline in apoptosis rates (P<0.05). CONCLUSION HCTMPPK may inhibit oxidative stress responses in OGD/R cells by reducing ROS levels and MDA content while down-regulating the expression of Bax, Caspase-3, and cleaved Caspase-3 proteins. It appears to up-regulate Bcl-2 expression as well as p-PI3K/PI3K and p-AKT/AKT proteins; this action reduces cell apoptosis and diminishes infarct areas within ischemic tissue in I/R rats, thereby exerting a protective effect on brain tissue during stroke events. |
| Key words: Ligustrazine chalcone compounds HCTMPPK oxygen-glucose deprivation cerebral ischemia reperfusion PI3K/AkT |
|
|
|
|